Exports: In 2018, Germany exported $29.7B in Blood, antisera, vaccines, toxins and cultures, making it the 2nd largest exporter of Blood, antisera, vaccines, toxins and cultures in the world. At the same year, Blood, antisera, vaccines, toxins and cultures was the 5th most exported product in Germany. The main destination of Blood, antisera, vaccines, toxins and cultures exports from Germany are: Netherlands ($6.21B), United States ($3.3B), Italy ($2.93B), Switzerland ($2.46B), and United Kingdom ($1.81B).
The fastest growing export markets for Blood, antisera, vaccines, toxins and cultures of Germany between 2017 and 2018 were Netherlands ($2.29B), Italy ($1.53B), and Switzerland ($786M).
Imports: In 2018, Germany imported $19.1B in Blood, antisera, vaccines, toxins and cultures, becoming the 2nd largest importer of Blood, antisera, vaccines, toxins and cultures in the world. At the same year, Blood, antisera, vaccines, toxins and cultures was the 8th most imported product in Germany. Germany imports Blood, antisera, vaccines, toxins and cultures primarily from: Switzerland ($4.18B), United States ($2.84B), Netherlands ($2.82B), Belgium-Luxembourg ($1.99B), and Ireland ($1.23B).
The fastest growing import markets in Blood, antisera, vaccines, toxins and cultures for Germany between 2017 and 2018 were Belgium-Luxembourg ($619M), Switzerland ($528M), and Italy ($353M).
Rnk 5 / 1217
